Evidence map›Paper›PMID 30363729›Full record

Trial reportContrast media & molecular imaging2018

Functional Parameters of

Jing Yang, Sha Zhu, Fuwen Pang, Miao Xu, Yiting Dong, Jianqi Hao, Xuelei Ma

Open access · hybridAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Contrast media & molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Prognostic Values of BaselineBioMed research international · 2020
    Article
  3. Physiologic Testicular Uptake of 18-F Fluorodeoxyglucose in the Indian Population.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jing YangState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.
Sha ZhuWest China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Fuwen PangWest China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Miao XuDepartment of Pathology, West China Hospital, Sichuan University, Chengdu, China.
Yiting DongWest China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Jianqi HaoWest China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Xuelei MaState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, China.ORCID 0000-0002-9148-5001
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorine-18 fluorodeoxyglucose (

Indexed as

Fluorodeoxyglucose F18Lymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographyTesticular NeoplasmsAdultAgedHumansMaleMiddle AgedRetrospective StudiesFluorodeoxyglucose F18

Identifiers

PMID30363729
PMCPMC6180978
OpenAlexW2893227843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.